Identification of eczema clusters and their association with filaggrin and atopic comorbidities: analysis of five birth cohorts
Identification of eczema clusters and their association with filaggrin and atopic comorbidities: analysis of five birth cohorts
Background: longitudinal modelling of the presence/absence of current eczema through childhood has identified similar phenotypes, but their characteristics often differ between studies.
Objectives: to demonstrate that a more comprehensive description of longitudinal pattern of symptoms may better describe trajectories than binary information on eczema presence.
Methods: we derived six multidimensional variables of eczema spells from birth to 18 years of age (including duration, temporal sequencing and the extent of persistence/recurrence). Spells were defined as consecutive observations of eczema separated by no eczema across 5 epochs in five birth cohorts: infancy (first year); early childhood (age 2–3 years); preschool/early school age (4–5 years); middle childhood (8–10 years); adolescence (14–18 years). We applied Partitioning Around Medoids clustering on these variables to derive clusters of the temporal patterns of eczema. We then investigated the stability of the clusters, within-cluster homogeneity and associated risk factors, including FLG mutations.
Results: analysis of 7464 participants with complete data identified five clusters: (i) no eczema (51.0%); (ii) early transient eczema (21.6%); (iii) late-onset eczema (LOE; 8.1%); (iv) intermittent eczema (INT; 7.5%); and (v) persistent eczema (PE; 11.8%). There was very-high agreement between the assignment of individual children into clusters when using complete or imputed (n = 15 848) data (adjusted Rand index = 0.99; i.e. the clusters were very stable). Within-individual symptom patterns across clusters confirmed within-cluster homogeneity, with consistent patterns of symptoms among participants within each cluster and no overlap between the clusters. Clusters were characterized by differences in associations with risk factors (e.g. parental eczema was associated with all clusters apart from LOE; sensitization to inhalant allergens was associated with all clusters, with the highest risk in the PE cluster). All clusters apart from LOE were associated with FLG mutations. Of note, the strongest association was for PE [relative risk ratio (RRR) 2.70, 95% confidence interval (CI) 2.24–3.26; P < 0.001] followed by INT (RRR 2.29, 95% CI 1.82–2.88; P < 0.001).
Conclusions: clustering of multidimensional variables identified stable clusters with different genetic architectures. Using multidimensional variables may capture eczema development and derive stable and internally homogeneous clusters. However, deriving homogeneous symptom clusters does not necessarily mean that these are underpinned by completely unique mechanisms.
45-54
Haider, Sadia
ed3296e0-288d-49b1-befb-fe4545a7278e
Granell, Raquel
06e9e006-3754-4cc9-b3fc-42024bd05123
Curtin, John A.
b1f4f316-b8a3-438f-aeab-4c411ab41da2
Holloway, John W.
4bbd77e6-c095-445d-a36b-a50a72f6fe1a
Fontanella, Sara
6c29b69f-edd6-4414-a8fd-c47241976aa5
Hasan Arshad, Syed
917e246d-2e60-472f-8d30-94b01ef28958
Murray, Clare S.
aca69df6-149c-401c-842f-5b2d8042edf1
Cullinan, Paul
b5b2eb0a-9fb9-4d4b-af18-5109de92d742
Turner, Stephen
a51d875a-66bb-4a18-b5b0-18ce3dc7d15c
Roberts, Graham
ea00db4e-84e7-4b39-8273-9b71dbd7e2f3
Simpson, Angela
5591f945-0ead-46a3-a866-b7bea84a2a83
Custovic, Adnan
17d8d092-73b8-44fb-bf48-5cea7b29e3fc
20 December 2023
Haider, Sadia
ed3296e0-288d-49b1-befb-fe4545a7278e
Granell, Raquel
06e9e006-3754-4cc9-b3fc-42024bd05123
Curtin, John A.
b1f4f316-b8a3-438f-aeab-4c411ab41da2
Holloway, John W.
4bbd77e6-c095-445d-a36b-a50a72f6fe1a
Fontanella, Sara
6c29b69f-edd6-4414-a8fd-c47241976aa5
Hasan Arshad, Syed
917e246d-2e60-472f-8d30-94b01ef28958
Murray, Clare S.
aca69df6-149c-401c-842f-5b2d8042edf1
Cullinan, Paul
b5b2eb0a-9fb9-4d4b-af18-5109de92d742
Turner, Stephen
a51d875a-66bb-4a18-b5b0-18ce3dc7d15c
Roberts, Graham
ea00db4e-84e7-4b39-8273-9b71dbd7e2f3
Simpson, Angela
5591f945-0ead-46a3-a866-b7bea84a2a83
Custovic, Adnan
17d8d092-73b8-44fb-bf48-5cea7b29e3fc
Haider, Sadia, Granell, Raquel, Curtin, John A., Holloway, John W., Fontanella, Sara, Hasan Arshad, Syed, Murray, Clare S., Cullinan, Paul, Turner, Stephen, Roberts, Graham, Simpson, Angela and Custovic, Adnan
(2023)
Identification of eczema clusters and their association with filaggrin and atopic comorbidities: analysis of five birth cohorts.
British Journal of Dermatology, 190 (1), , [ljad326].
(doi:10.1093/bjd/ljad326).
Abstract
Background: longitudinal modelling of the presence/absence of current eczema through childhood has identified similar phenotypes, but their characteristics often differ between studies.
Objectives: to demonstrate that a more comprehensive description of longitudinal pattern of symptoms may better describe trajectories than binary information on eczema presence.
Methods: we derived six multidimensional variables of eczema spells from birth to 18 years of age (including duration, temporal sequencing and the extent of persistence/recurrence). Spells were defined as consecutive observations of eczema separated by no eczema across 5 epochs in five birth cohorts: infancy (first year); early childhood (age 2–3 years); preschool/early school age (4–5 years); middle childhood (8–10 years); adolescence (14–18 years). We applied Partitioning Around Medoids clustering on these variables to derive clusters of the temporal patterns of eczema. We then investigated the stability of the clusters, within-cluster homogeneity and associated risk factors, including FLG mutations.
Results: analysis of 7464 participants with complete data identified five clusters: (i) no eczema (51.0%); (ii) early transient eczema (21.6%); (iii) late-onset eczema (LOE; 8.1%); (iv) intermittent eczema (INT; 7.5%); and (v) persistent eczema (PE; 11.8%). There was very-high agreement between the assignment of individual children into clusters when using complete or imputed (n = 15 848) data (adjusted Rand index = 0.99; i.e. the clusters were very stable). Within-individual symptom patterns across clusters confirmed within-cluster homogeneity, with consistent patterns of symptoms among participants within each cluster and no overlap between the clusters. Clusters were characterized by differences in associations with risk factors (e.g. parental eczema was associated with all clusters apart from LOE; sensitization to inhalant allergens was associated with all clusters, with the highest risk in the PE cluster). All clusters apart from LOE were associated with FLG mutations. Of note, the strongest association was for PE [relative risk ratio (RRR) 2.70, 95% confidence interval (CI) 2.24–3.26; P < 0.001] followed by INT (RRR 2.29, 95% CI 1.82–2.88; P < 0.001).
Conclusions: clustering of multidimensional variables identified stable clusters with different genetic architectures. Using multidimensional variables may capture eczema development and derive stable and internally homogeneous clusters. However, deriving homogeneous symptom clusters does not necessarily mean that these are underpinned by completely unique mechanisms.
Text
ljad326 (1)
- Version of Record
More information
Accepted/In Press date: 1 September 2023
e-pub ahead of print date: 3 November 2023
Published date: 20 December 2023
Additional Information:
Funding Information:
The UNICORN consortium was funded by the Medical Research Council Programme Grant MR/S025340/1; the STELAR consortium was funded through the Medical Research Council grants G0601361 and MR/K002449/1. Infrastructure support for this research was provided by the National Institute for Health and Care Research Imperial Biomedical Research Centre (BRC). The UK MRC and Wellcome (grant ref: 217065/Z/19/Z), and the University of Bristol provide core support for the Avon Longitudinal Study of Parents and Children (ALSPAC). This publication is the work of the authors and Adnan Custovic, and R.G. will serve as guarantor for the contents of this paper. A comprehensive list of grant funding is available on the ALSPAC website ( http://www.bristol.ac.uk/alspac/external/documents/grant-acknowledgements.pdf ). The Manchester Asthma and Allergy Study (MAAS) was supported by Asthma UK grants no. 301 (1995–1998), no. 362 (1998–2001), no. 01/012 (2001–2004) and no. 04/014 (2004–2007); the BMA James Trust (2005) and the JP Moulton Charitable Foundation (2004–2016); the North West Lung Centre Charity (1997–current); and MRC grant MR/L012693/1 (2014–2018). The Isle of Wight cohort was supported by the Isle of Wight Health Authority, the National Asthma Campaign, UK (grant no. 364) and National Institutes of Health grants R01 HL082925-01, R01 AI091905 and R01 AI121226.
Publisher Copyright:
© 2024 Blackwell Publishing Ltd. All rights reserved.
© The Author(s) 2023. Published by Oxford University Press on behalf of British Association of Dermatologists.
Identifiers
Local EPrints ID: 484390
URI: http://eprints.soton.ac.uk/id/eprint/484390
ISSN: 0007-0963
PURE UUID: fcd87f0f-dfae-413e-9785-001c0e6a54e0
Catalogue record
Date deposited: 16 Nov 2023 11:45
Last modified: 10 Aug 2024 01:40
Export record
Altmetrics
Contributors
Author:
Sadia Haider
Author:
Raquel Granell
Author:
John A. Curtin
Author:
Sara Fontanella
Author:
Clare S. Murray
Author:
Paul Cullinan
Author:
Stephen Turner
Author:
Angela Simpson
Author:
Adnan Custovic
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics